Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Brief Description  
A Phase III, Multicenter, Randomised, Double-Blind, Parallel Group, Placebo Controlled Study to Assess the Efficacy and Safety of one or more Intradetrusor Treatments of 600 or 800 Units of Dysport for the Treatment of Urinary Incontinence in Subjects With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury or Multiple Sclerosis
Who may be Eligible  
Male or female, aged 18 to 80 years inclusive with UI for at least 3 months prior to screening as a result of NDQ due to SCI or MS.
Start Date  
IRB Number  
Principal Investigator  
Kennelly, Michael
Contact Name  

For More Information, Contact  Ali  , DeMarco
Phone:  (704) 355-1970  Fax:  (704) 355-0000  
Email:  Ali.Demarco@carolinashealthcare.org
Address:1023 Edgehill Road Charlotte, NC 28207